Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Miscellaneous · ·
$4.51
▼ $0.02 (-0.4%)
Market data updated: 09/18 09:30 PM
Fundamentals updated: 09/18/2026
News analyzed: 09/18/2026
Market Cap
$440.12M
Day Range
$4.39 - $4.53
52-Week Range
$3.15 - $5.27
Beta
—
Next Earnings
03.11.2026
Support
$4.29
Resistance
$4.99
+32.6% (1Y)
Strengths: 13/28 factors positiveRisk: Medium
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟡 Mixed
Technical Trend
🔴 Bearish
Insiders
🔴 Bearish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Revenue growth (last year)
Revenue growth (last year): 133.2%
Growth
Biggest negative driver
Calmar Ratio (return vs. drawdown)
Calmar: 0.14 (3y annualized return 7.1% / max drawdown 50.0%)
Risk
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 2 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 2
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
59
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
74
Quality
63
Value
55
Momentum
41
Risk
54
Sentiment
86
Fundamental
58
Institutional
0
Stocks with a similar DNA right now
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Recent media coverage of Acacia Research Corporation has centered on its **record-breaking Q2 2026 earnings**, with revenue surging **124% to $114.6 million**—primarily driven by a major **intellectual property licensing settlement** and strong performance in its energy sector. However, the company also faced a **write-down in its Life Sciences division**, offsetting some gains. Analysts highlighted strategic shifts and operational improvements as key themes.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about Acacia Research Corporation. News trend score: 86. Reason: 6 of the last 15 articles are positive, versus 0 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
15
🎯 Conviction (vs. Emotion)
44
Psychology
29
Fundamentals
58
Technical
41
Valuation
55
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
Extreme momentum, price far above its moving average, and a large premium over fair value.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
The price is holding at a real, documented historical support/resistance level (a 50-day high or low).
Price (3M)
-7%
Market Narrative
58
Fundamental Reality
44
Narrative Gap
+14
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 StockIQ Psychologist
The market behavior for ACTG suggests a **narrative-reality disconnect** (gap: 14) with traders anchored near support (3.7% above) but lacking clear momentum or extreme sentiment. The absence of panic or herding implies cautious positioning, while neutral RSI (49) and modest volume (0.89x avg) rule out FOMO or euphoria. The dominant psychological state—**anchoring**—implies traders may be waiting for confirmation near support, but the key question remains: *Will the stock break below this level, or will it stabilize?*
Updated: 09/08/2026, 10:47 PM
What could change this?
👥 What the crowd believes
"IP licensing settlement drives record $114.6M revenue"
"revenue of $114.6 million, up from $51.2 million in the prior-year period"
"record energy performance"
"navigating a life sciences writedown"
📈 13D Investor Psychology
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Walter Bagehot — 100/100
🔴 Weakest match
Jack Schwager — 38/100
🗣️ Why do they disagree?
The stark divide in verdicts for ACTG reflects deep methodological differences in how these investors evaluate stocks. Walter Bagehot’s near-perfect score highlights his focus on liquidity and resilience during crises, suggesting the stock’s financial health could weather downturns—something growth-oriented investors like Peter Lynch (96) and Edgar Lawrence Smith (73) overlook in favor of potential upside. Meanwhile, Benjamin Graham’s defensive approach (78) and enterprising bar (62) show moderate interest, balancing valuation with risk, while Philip Fisher (69) and Howard Marks (60) temper enthusiasm, noting either mediocre quality or already-priced-in expectations. At the opposite end, Jesse Livermore’s low score (16) aligns with his contrarian trend-following bias, dismissing the stock outright, whereas patient, long-term thinkers like Morgan Housel (65) and Samuel Nelson (64) see quiet, sustainable potential—underscoring how time horizons shape conclusions. Even efficient-market skeptics (56) and behavioral economists like Thorstein Veblen (56) struggle to find clear conviction, leaving ACTG as a stock where fundamentals, momentum, and investor temperament clash.
Walter Bagehot
Lombard Street (1873)
🟢 100
Strong liquidity — would likely survive a real credit squeeze
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🟢 96
Growth candidate — the price hasn't caught up to the growth
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟢 79
Attractive to a Defensive Graham Investor
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🟢 74
The kind of quiet compounder a patient holder could actually stick with
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟢 73
Looks like a real 'buy and hold for a decade' candidate
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 72
No obvious signs of crowd mania
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟢 71
Reasonable capital-preservation profile
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🟢 69
Solid, but not the exceptional quality Fisher looked for
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 68
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🟡 62
Some discount, but not the deep 'net-net' bargain Graham's enterprising bar sets
Key question
Is the stock statistically cheap enough to justify the extra risk?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 61
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟡 57
Mixed — a good business, but expectations may already be high
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟡 56
Mixed signal on whether growth translates to real profit
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟡 48
Somewhere in the middle of the cycle
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🟡 41
Negative trend — against Livermore's core rule of trading with the trend
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟡 38
No real setup here — the discipline Schwager's wizards shared would say stay out
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Based on the last 280 trading days, calculated from real price data. Click an indicator for details and a chart.
🔴 Most indicators support a downtrend (2 bullish · 5 bearish · 3 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
A pattern consistent with an early/mid accumulation phase — a trading range after a decline with declining volume.
Medium confidence
$4.29
Range Bottom
$4.99
Range Top
50
Trading Days in Range
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
41.1%
Operating Margin
7.8%
Net Margin
7.6%
EBITDA Margin
—
ROE
4.0%
ROA
2.8%
ROIC
—
EPS
$0.23
Cash
$306.72M
Total Debt
$91.90M
Current Ratio
9.18
Debt/Equity
0.17
How is Fair Value calculated? →
Not enough cash-flow data to calculate a DCF model for this stock.
Book Value per Share
$5.63
Tangible Book Value per Share (Tangible NAV)
$5.13
Sentiment based on basic keywords (not AI) — 6 positive, 9 neutral, 0 negative out of the last 15 articles.
Motley Fool · 13.8.2026
Yahoo · 13.8.2026
SeekingAlpha · 7.8.2026
GuruFocus.com · 5.8.2026
Yahoo · 5.8.2026
Moby · 5.8.2026
Yahoo · 5.8.2026
MarketBeat · 5.8.2026
Yahoo · 5.8.2026
Business Wire · 5.8.2026
Yahoo · 5.8.2026
ChartMill · 5.8.2026
SeekingAlpha · 5.8.2026
Benzinga · 5.8.2026
Business Wire · 22.7.2026
Acacia Research Corporation (ACTG) currently has a StockIQ AI score of 59/100, rated "Moderate". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
ACTG currently scores 59/100 (Moderate) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
ACTG's technical score is 41/100, which currently reads as neutral — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Revenue growth (last year): 133.2%; Earnings per share (EPS) growth: 161.1%; Net income growth: 160.1%.
Based on the real signals StockIQ computed: Calmar: 0.14 (3y annualized return 7.1% / max drawdown 50.0%); Price is below the 50-day average; -9.1% over the last 3 months relative to the index.
StockIQ has no recorded dividend payment history for ACTG.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 5 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| OCONNELL MAUREEN | Open Market Sale | 3.9.2026 | 12,466 | -12,466 | $4.57 |
| OCONNELL MAUREEN | Open Market Sale | 2.9.2026 | 20,534 | -20,534 | $4.63 |
| FELMAN MICHELLE | Gift | 28.8.2026 | 16,086 | -16,086 | $4.49 |
| FELMAN MICHELLE | Gift | 28.8.2026 | 16,086 | -16,086 | $4.49 |
| OCONNELL MAUREEN | Open Market Sale | 19.8.2026 | 10,000 | -10,000 | $4.60 |
| Kohlberg Isaac T. | Open Market Sale | 12.8.2026 | 32,188 | -32,188 | $4.67 |
| Kohlberg Isaac T. | Open Market Sale | 12.8.2026 | 78,310 | -32,188 | $4.67 |
| Molinelli Gavin | Grant/Award from Employer | 30.6.2026 | 6,438 | +6,438 | $4.66 |
| Molinelli Gavin | Grant/Award from Employer | 30.6.2026 | 205,966 | +6,438 | $4.66 |
| Sundar Ajay | Grant/Award from Employer | 23.6.2026 | 4,175 | +4,175 | $4.79 |
| Kohlberg Isaac T. | Grant/Award from Employer | 23.6.2026 | 25,052 | +25,052 | — |
| OCONNELL MAUREEN | Grant/Award from Employer | 23.6.2026 | 25,052 | +25,052 | — |
| FELMAN MICHELLE | Grant/Award from Employer | 23.6.2026 | 25,052 | +25,052 | — |
| Molinelli Gavin | Grant/Award from Employer | 23.6.2026 | 25,052 | +25,052 | — |
| OCONNELL MAUREEN | Grant/Award from Employer | 23.6.2026 | 297,655 | +25,052 | — |
| FELMAN MICHELLE | Grant/Award from Employer | 23.6.2026 | 57,224 | +25,052 | — |
| Molinelli Gavin | Grant/Award from Employer | 23.6.2026 | 199,528 | +25,052 | — |
| Kohlberg Isaac T. | Grant/Award from Employer | 23.6.2026 | 110,498 | +25,052 | — |
| Sundar Ajay | Grant/Award from Employer | 23.6.2026 | 107,605 | +4,175 | $4.79 |
| Rasamny Robert | Tax Withholding in Shares | 8.6.2026 | 28,390 | -28,390 | $4.62 |
| Soncini Jason W. | Tax Withholding in Shares | 8.6.2026 | 48,985 | -48,985 | $4.62 |
| McNulty Martin D. Jr. | Tax Withholding in Shares | 8.6.2026 | 287,133 | -287,133 | $4.62 |
| McNulty Martin D. Jr. | Tax Withholding in Shares | 8.6.2026 | 418,430 | -287,133 | $4.62 |
| Soncini Jason W. | Tax Withholding in Shares | 8.6.2026 | 235,615 | -48,985 | $4.62 |
| Rasamny Robert | Tax Withholding in Shares | 8.6.2026 | 73,976 | -28,390 | $4.62 |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
2,027,654 shares short as of 2026-08-31 · vs. 2,006,551 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
51.5% of trading volume this week was short selling, vs. 44.2% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology